C
Com2uSCorp
KOSDAQ:078340
Com2uSCorp
KOSDAQ:078340
Price:
51 800
KRW
1.57%
Market Closed
Market Cap:
591.3B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Com2uSCorp
51800
+800 (+1.57%)
| 52 Week Range |
34 550
52 600
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Com2uSCorp
Balance Sheet
Balance Sheet Decomposition
Com2uSCorp
Com2uSCorp
| Current Assets | 425.8B |
| Cash & Short-Term Investments | 258.8B |
| Receivables | 104.8B |
| Other Current Assets | 62.3B |
| Non-Current Assets | 1.3T |
| Long-Term Investments | 917.3B |
| PP&E | 58.3B |
| Intangibles | 259.5B |
| Other Non-Current Assets | 82.8B |
| Current Liabilities | 384.8B |
| Accrued Liabilities | 21.7B |
| Short-Term Debt | 169.4B |
| Other Current Liabilities | 193.6B |
| Non-Current Liabilities | 257.2B |
| Long-Term Debt | 95.6B |
| Other Non-Current Liabilities | 161.5B |
Balance Sheet
Com2uSCorp
Com2uSCorp
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
12 064
|
84 839
|
90 001
|
25 792
|
32 804
|
35 695
|
58 000
|
253 740
|
173 215
|
143 194
|
|
| Cash Equivalents |
12 064
|
84 839
|
90 001
|
25 792
|
32 804
|
35 695
|
58 000
|
253 740
|
173 215
|
143 194
|
|
| Short-Term Investments |
118 019
|
352 500
|
479 535
|
643 069
|
664 246
|
664 959
|
589 025
|
264 929
|
251 155
|
168 992
|
|
| Total Receivables |
42 313
|
67 126
|
68 145
|
82 153
|
61 666
|
56 212
|
57 866
|
85 201
|
110 621
|
97 818
|
|
| Accounts Receivables |
38 288
|
64 537
|
65 246
|
79 167
|
60 053
|
55 452
|
56 877
|
81 604
|
94 916
|
83 844
|
|
| Other Receivables |
4 025
|
2 589
|
2 899
|
2 986
|
1 613
|
760
|
989
|
3 597
|
15 705
|
13 974
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 209
|
10 133
|
8 878
|
|
| Other Current Assets |
1 430
|
3 134
|
16 628
|
17 003
|
15 289
|
8 678
|
11 188
|
34 830
|
52 456
|
29 739
|
|
| Total Current Assets |
173 826
|
507 599
|
654 308
|
768 018
|
774 007
|
765 543
|
716 080
|
644 909
|
597 581
|
448 621
|
|
| PP&E Net |
2 898
|
3 385
|
2 589
|
2 872
|
2 949
|
14 538
|
13 107
|
86 819
|
97 605
|
58 793
|
|
| PP&E Gross |
2 898
|
3 385
|
2 589
|
2 872
|
2 949
|
14 538
|
13 107
|
86 819
|
97 605
|
0
|
|
| Accumulated Depreciation |
4 861
|
6 396
|
6 963
|
7 206
|
7 966
|
10 831
|
16 890
|
34 268
|
44 909
|
0
|
|
| Intangible Assets |
2 294
|
2 902
|
2 566
|
2 724
|
1 971
|
7 260
|
13 004
|
125 796
|
109 100
|
74 680
|
|
| Goodwill |
0
|
0
|
0
|
0
|
93
|
12 579
|
33 299
|
217 413
|
246 420
|
191 422
|
|
| Note Receivable |
210
|
0
|
0
|
0
|
459
|
459
|
473
|
211
|
20 000
|
20 863
|
|
| Long-Term Investments |
63 834
|
60 819
|
52 344
|
63 979
|
129 477
|
195 772
|
259 809
|
743 795
|
764 988
|
847 519
|
|
| Other Long-Term Assets |
6 628
|
7 443
|
179
|
718
|
345
|
8 827
|
13 361
|
39 862
|
63 151
|
74 115
|
|
| Other Assets |
0
|
0
|
0
|
0
|
93
|
12 579
|
33 299
|
217 413
|
246 420
|
191 422
|
|
| Total Assets |
249 689
N/A
|
582 148
+133%
|
711 986
+22%
|
838 311
+18%
|
909 301
+8%
|
1 004 978
+11%
|
1 049 132
+4%
|
1 858 805
+77%
|
1 898 846
+2%
|
1 716 013
-10%
|
|
| Liabilities | |||||||||||
| Accrued Liabilities |
762
|
336
|
537
|
636
|
943
|
457
|
0
|
0
|
8 525
|
23 108
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1 100
|
39 297
|
106 995
|
15 040
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2 603
|
3 270
|
14 739
|
12 143
|
129 125
|
|
| Other Current Liabilities |
31 244
|
68 057
|
73 900
|
75 877
|
62 282
|
67 676
|
61 570
|
121 215
|
192 436
|
178 729
|
|
| Total Current Liabilities |
32 006
|
68 393
|
74 438
|
76 513
|
63 225
|
70 736
|
65 941
|
175 251
|
320 099
|
346 002
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
6 163
|
3 743
|
198 178
|
199 073
|
83 708
|
|
| Deferred Income Tax |
5 542
|
3 790
|
1 290
|
272
|
110
|
446
|
0
|
66 035
|
42 985
|
39 118
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
454
|
5 773
|
3 847
|
239 088
|
183 871
|
122 089
|
|
| Other Liabilities |
1 564
|
958
|
1 276
|
595
|
1 470
|
2 189
|
2 341
|
6 400
|
13 855
|
10 418
|
|
| Total Liabilities |
39 112
N/A
|
73 142
+87%
|
77 003
+5%
|
77 379
+0%
|
65 258
-16%
|
85 308
+31%
|
75 872
-11%
|
684 952
+803%
|
759 883
+11%
|
601 336
-21%
|
|
| Equity | |||||||||||
| Common Stock |
5 043
|
6 433
|
6 433
|
6 433
|
6 433
|
6 433
|
6 433
|
6 433
|
6 433
|
6 433
|
|
| Retained Earnings |
157 228
|
283 032
|
434 784
|
559 711
|
675 166
|
769 745
|
833 055
|
945 196
|
966 189
|
967 108
|
|
| Additional Paid In Capital |
26 391
|
205 061
|
205 061
|
205 061
|
205 589
|
205 061
|
205 061
|
205 061
|
205 061
|
205 061
|
|
| Unrealized Security Profit/Loss |
21 920
|
13 300
|
6 617
|
6 565
|
718
|
1 800
|
2 733
|
109 129
|
40 974
|
33 933
|
|
| Treasury Stock |
3 111
|
3 649
|
23 135
|
20 365
|
46 076
|
63 339
|
77 669
|
97 255
|
98 268
|
118 994
|
|
| Other Equity |
3 105
|
4 829
|
5 222
|
3 526
|
3 647
|
3 570
|
3 647
|
5 288
|
18 574
|
21 136
|
|
| Total Equity |
210 577
N/A
|
509 006
+142%
|
634 983
+25%
|
760 931
+20%
|
844 043
+11%
|
919 670
+9%
|
973 261
+6%
|
1 173 853
+21%
|
1 138 963
-3%
|
1 114 677
-2%
|
|
| Total Liabilities & Equity |
249 689
N/A
|
582 148
+133%
|
711 986
+22%
|
838 311
+18%
|
909 301
+8%
|
1 004 978
+11%
|
1 049 132
+4%
|
1 858 805
+77%
|
1 898 846
+2%
|
1 716 013
-10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
11
|
13
|
13
|
13
|
12
|
12
|
12
|
12
|
12
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
